↓ Skip to main content
What is this page? Embed badge

A phase I, open-label, single-arm, dose-escalation study of E7107, a precursor messenger ribonucleic acid (pre-mRNA) splicesome inhibitor administered intravenously on days 1 and 8 every 21 days to…

Overview of attention for article published in Investigational New Drugs, November 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

blogs
1 blog
twitter
1 X user
patent
2 patents

Citations

dimensions_citation
170 Dimensions

Readers on

mendeley
118 Mendeley
Summary Blogs X Patents Dimensions citations
So far, Altmetric has seen 2 patents that reference this research output.

This page is provided by Altmetric.